Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
As the day draws to a close, we await the House vote on the FDA bill and an update will be provided as news emerges. Meanwhile, the evening rolls on. Here a few items to tide you over....
Adnexus Hires Glaxo's Avandia Clinical Development Head (Boston Business Journal)
Pharmacists Seek Law To Block Pay Cuts (Yahoo/AP)
Genentech Profit Rose 41 Percent In 2nd Quarter (Bloomberg News)
Abbott And GE End Diagnostics Deal (Yahoo/Reuters)
